 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | BIIB110 / Biogen
Trial completion: A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ALG-801 in Healthy Postmenopausal Women (EUDRACT) - Apr 5, 2024
P1, N=32, Completed, Sponsor: AliveGen USA, Inc.
Not yet recruiting --> Completed